T
Terns Pharmaceuticals D
D
TERN
7.78000
USD
0.04
(0.52%)
Market Closed
Volume
33,368
EPS
0
Div Yield
0
P/E
-5
Market Cap
585,563,376
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks newsTitle: Terns Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.